With the recent publication of the 6th edition of the World Health Organization (WHO) Classification of Soft Tissue and Bone Tumors, this webinar will provide an overview of the most important changes in soft tissue tumor classification—emphasizing new entities, evolving concepts, and novel “next-generation” IHC markers that can be used in place of molecular genetic analysis. The content is suitable for those who practice in both academic and community settings.
Objectives:
- Develop a differential diagnosis for soft tissue tumors.
- Apply IHC using novel markers to help resolve the differential diagnosis.
- Understand selected situations to order molecular genetic testing.
Speaker:
Jason L. Hornick, MD, PhD, FCAP
Register:
This webinar is offered twice on December 9, 2026. Both sessions cover the same content, so attend whichever time works best for you.
8:00 am Central: Register
8:00 pm Central: Register
Webinar registrants receive a recording after the event.